Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse model
Jendrach, M.; Freitag, K.; Sterczyk, N.; Obermayer, B.; Schulz, J.; Houtman, J.; Fleck, L.; Braeuning, C.; Sanseverino, R.; Hoffmann, C.; Milovanovic, D.; Sigrist, S. J.; Conrad, T.; Beule, D.; Heppner, F. L.
Show abstract
Deposition of amyloid beta (A{beta}) along with glia cell-mediated neuroinflammation are prominent pathogenic hallmarks of Alzheimers disease (AD). In recent years, impairment of autophagy has been found to be another important feature, contributing to AD progression and aging. Therefore, we assessed the effect of the autophagy activator Spermidine, a small body-endogenous polyamine often used as dietary supplement and known to promote longevity, on glia cell-mediated neuroinflammation. Spermidine reduced TLR3- and TLR4- mediated inflammatory processes in microglia and astrocytes by decreasing cytotoxicity, inflammasome activity and NF-{kappa}B signaling. In line with these anti-inflammatory effects, oral treatment of the amyloid prone AD-like APPPS1 mice with Spermidine reduced neuroinflammation and neurotoxic soluble A{beta}. Mechanistically, single nuclei sequencing revealed microglia as one of the main targets of Spermidine treatment, with increased expression of genes implicated in cell motility and phagocytosis. Thus, Spermidine provides a promising therapeutic potential to target glia cells in AD progression.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer's disease 97%
- Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity 96%
- IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease. 96%
Similar papers in this journal
- Diabetic phenotype in mouse and humans with β-amyloid pathology reduces the number of microglia around β-amyloid plaques 96%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- Amyloid plaque deposition accelerates tau propagation via activation of microglia in a humanized APP mouse model 95%
Similar papers in this journal
- Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer's disease-like pathology in human cerebral organoids 96%
- Alzheimer's Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery 95%
- SARS-CoV-2 promotes microglial synapse elimination in human brain organoids 95%
Similar papers in this journal
- SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration 96%
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases 96%
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.